| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.05 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |